药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tazarotene
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Arsenic trioxide.
Tazarotene
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Arsenic trioxide.
Tazarotene
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Arsenic trioxide.
Tazarotene
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Arsenic trioxide.
Tazarotene
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Arsenic trioxide.
Tazarotene
Mepyramine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Arsenic trioxide.
Tazarotene
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Arsenic trioxide.
Tazarotene
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Arsenic trioxide.
Tazarotene
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Arsenic trioxide.
Tazarotene
Levocetirizine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Arsenic trioxide.
Tazarotene
Vernakalant
The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Arsenic trioxide.
Tazarotene
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Arsenic trioxide.
Tazarotene
Methsuximide
The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Arsenic trioxide.
Tazarotene
Indacaterol
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Arsenic trioxide.
Tazarotene
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Arsenic trioxide.
Tazarotene
Celiprolol
The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Arsenic trioxide.
Tazarotene
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Arsenic trioxide.
Tazarotene
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Arsenic trioxide.
Tazarotene
Thiothixene
The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Arsenic trioxide.
Tazarotene
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Arsenic trioxide.